DrugsControl Media Services

News Detail

Novartis heart drug price may fall by 60% (19-01-2023)

New Delhi, 19 Jan 2023: The worth of prime promoting cardiac arrest drug sacubitril/valsartan offered by Swiss pharmaceutical firm Novartis and its companions in India is predicted fall as a lot as 60% with a number of Indian drugmakers gearing as much as launch its generic model......
View Details

Source : Economic Times
novartis cipla glenmark fortis escorts heart institute api eris lifesciences torrent pharma natco pharma sun pharma sacubitril/valsartan

Related News